Get the latest Science News and Discoveries
A trial HIV vaccine triggered elusive and essential antibodies in humans - EurekAlert
<p>An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.</p>
None
Or read this on Eureka Alert